glp-1 obesity drug news today september 2025 What to Know About New Weight Loss Pills GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Nuclear factor-B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans

When NAD levels decline, it results in a decrease in cellular energy, which can also be described as mitochondrial dysfunction a condition that is implicated in most chronic illnesses, including diabetes, autoimmune disorders, Alzheimers, multiple sclerosis and many more

In AMD and diabetic retinopathy where chronic inflammation damages retina, cytokine suppression reduces ongoing tissue destruction

Additionally, NIX has been identified as a substrate for Parkin, facilitating Parkin/PINK1-dependent mitophagy (Sandoval et al., 2008

A6 cell viability upon BSO and cysteine treatment was determined using MTT assay